DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
The generic ingredient in ESKALITH CR is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
Profile for product number 001
|Active Rx/OTC/Discontinued:||DISCN||Dosage:||TABLET, EXTENDED RELEASE;ORAL||Strength||450MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**|
|Approval Date:||Mar 29, 1982||TE:||RLD:||No|
Complete Access Available with Subscription